Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Language
Publication year range
1.
S Afr J Psychiatr ; 28: 1610, 2022.
Article in English | MEDLINE | ID: mdl-35281961

ABSTRACT

Background: Essential workers are imperative in the fight against the coronavirus disease (COVID-19) pandemic. Aim: To assess the prevalence and factors associated with anxiety and depression among essential workers during the COVID-19 pandemic and lockdown. Setting: This study was set in Ekiti State, Nigeria. Method: This was a cross-sectional study involving essential workers in Ekiti State Nigeria, during the COVID-19 pandemic and lockdown. A total of 588 essential workers were sampled. Online socio-demographic variables and the Hospital Anxiety and Depression Scale, a 14 item self-reported questionnaire were used. Results: The prevalence of anxiety and depression among the respondents was 93.4% (CI = 91.2-95.2) and 64.3% (CI = 60.4-68.4) respectively. Among the health workers, the prevalence of anxiety and depression were 96.5% (CI =94.8-98.1) and 66.5% (CI = 60.5-69.8) respectively while the prevalence of anxiety and depressive symptoms among non- health workers were 84.6% (CI = 78.7-90.1) and 61.5% (CI = 54.2-69.4) respectively. The odds ratio (OR) of depressive symptoms was increased among, respondents who were not satisfied with the support they received from the government during the pandemic (AOR = 2.071, CI = 1.350-2.213), respondents that were 35 years and younger (AOR = 1.512, CI = 1.033-2.213) and reduced amongst Christians (AOR = 0.501, CI = 0.286-0.879). The odd of anxiety was increased among health workers compared to non-health workers (AOR = 3.700, CI = 1.744-7.851) and the odds of anxiety was reduced among respondents with previous history of mental illness (AOR = 0.215, CI = 0.049-0.943). Conclusion: Anxiety and depressive symptoms were common mental illness among essential workers working during the COVID-19 lockdown, therefore their mental health should be adequately considered to sustain the fight against the virus.

2.
Article in English | AIM (Africa) | ID: biblio-1359257

ABSTRACT

Background: Essential workers are imperative in the fight against the coronavirus disease (COVID-19) pandemic. Aim: To assess the prevalence and factors associated with anxiety and depression among essential workers during the COVID-19 pandemic and lockdown. Setting: This study was set in Ekiti State, Nigeria. Method: This was a cross-sectional study involving essential workers in Ekiti State Nigeria, during the COVID-19 pandemic and lockdown. A total of 588 essential workers were sampled. Online socio-demographic variables and the Hospital Anxiety and Depression Scale, a 14 item self-reported questionnaire were used. Results: The prevalence of anxiety and depression among the respondents was 93.4% (CI = 91.2­95.2) and 64.3% (CI = 60.4­68.4) respectively. Among the health workers, the prevalence of anxiety and depression were 96.5% (CI =94.8­98.1) and 66.5% (CI = 60.5­69.8) respectively while the prevalence of anxiety and depressive symptoms among non- health workers were 84.6% (CI = 78.7­90.1) and 61.5% (CI = 54.2­69.4) respectively. The odds ratio (OR) of depressive symptoms was increased among, respondents who were not satisfied with the support they received from the government during the pandemic (AOR = 2.071, CI = 1.350­2.213), respondents that were 35 years and younger (AOR = 1.512, CI = 1.033­2.213) and reduced amongst Christians (AOR = 0.501, CI = 0.286­0.879). The odd of anxiety was increased among health workers compared to non-health workers (AOR = 3.700, CI = 1.744­7.851) and the odds of anxiety was reduced among respondents with previous history of mental illness (AOR = 0.215, CI = 0.049­0.943). Conclusion: Anxiety and depressive symptoms were common mental illness among essential workers working during the COVID-19 lockdown, therefore their mental health should be adequately considered to sustain the fight against the virus.


Subject(s)
Anxiety , Prevalence , Health Personnel , Depression , COVID-19 , Signs and Symptoms , Pandemics
3.
Ther Adv Psychopharmacol ; 3(5): 275-7, 2013 Oct.
Article in English | MEDLINE | ID: mdl-24167703

ABSTRACT

Clozapine is regarded as a second-line and in some cases last-line antipsychotic known for its common life-threatening side effects, such as agranulocytosis, constipation and cardiomyopathies, but rarely haematemesis. We report a case of severe haemetemesis in a chronic schizophrenic patient managed with clozapine. The patient was a 46-year-old male being managed for chronic schizophrenia with treatment resistance who developed sudden severe haematemesis following commencement of clozapine for 6 weeks. The patient had 1.1 l of blood transfusion. The relevant literature is reviewed. Clozapine can be associated with a life-threatening haematemesis. Psychiatrists and other medical specialists need to be alert to the fatality of clozapine-induced haematemesis in the treatment of psychiatric disorders.

4.
Psychol Rep ; 100(3 Pt 1): 876-82, 2007 Jun.
Article in English | MEDLINE | ID: mdl-17688106

ABSTRACT

The study investigated cognitive impairment and quality of life (QOL) among 109 consecutive stroke survivors and 109 normal controls. Each group comprised 64 (58.7%) men and 45 (41.3%) women. The modified Mini Mental State Examination (mMMSE) and the WHO Quality of Life Questionnaire (WHOQOL-Bréf) indicated that 19 (17.4%) stroke survivors had cognitive deficits (mMMSE score <16) compared with 5 (4.6%) control participants (chi1(2)=4.27, p<.05). Control participants performed significantly better on orientation, language comprehension, laterality, and the WHOQOL-Bréf. Being GHQ-30 positive predicted poor performance on the mMMSE among the stroke survivors and reduced QOL on three of the four domains of the WHOQOL-Bréf. In addition, previous psychiatric illness, paresis, low education, and shorter time elapsed after a stroke predicted reduced QOL on one or more domains of the WHOQOL-Bréf but age and sex of the stroke survivors were not associated with quality of life, and not with cognitive function.


Subject(s)
Cognition Disorders , Quality of Life/psychology , Stroke/ethnology , Adult , Aged , Aged, 80 and over , Cognition Disorders/diagnosis , Cognition Disorders/ethnology , Cognition Disorders/psychology , Female , Humans , Male , Middle Aged , Neuropsychological Tests , Nigeria/epidemiology , Patient Satisfaction , Severity of Illness Index , Stroke/mortality , Stroke/psychology , Surveys and Questionnaires , Survival Rate
SELECTION OF CITATIONS
SEARCH DETAIL
...